Pregabalin versus pramipexole for restless legs syndrome

New England Journal of Medicine

Volumn 370, Issue 21, 2014, Pages 2050-

  Coleman, Patrick ^a  

^a MANLY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; PRAMIPEXOLE; PREGABALIN; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE;

DRUG EFFICACY; DRUG SAFETY; HUMAN; IRON THERAPY; LETTER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; FEMALE; MALE; NOTE;

ANTICONVULSANTS; BENZOTHIAZOLES; DOPAMINE AGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; RESTLESS LEGS SYNDROME;

EID: 84901068249     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1402987     Document Type: Letter

References (4)

1. Allen RP. Pathophysiology: the biology of restless legs syndrome (Willis-Ekbom disease). In: Chokroverty S, Allen RP, Walters AS, Montagna P, eds. Sleep and movement disorders. 2nd ed. New York: Oxford University Press, 2013:585-97.
2. Tilma J, Tilma K, Norregaard O, Ostergaard JR. Early childhood-onset restless legs syndrome: symptoms and effect of oral iron treatment. Acta Paediatrica 2013;102(5):e221-e226.
3. Picchietti DL, Wang VC, Picchietti MA. Intravenous iron given prior to pregnancy for restless legs syndrome is associated with remission of symptoms. J Clin Sleep Med 2012;8:585-6.
4. Cho YW, Allen RP, Earley CJ. Lower molecular weight intravenous iron dextran for restless legs syndrome. Sleep Med 2013;14:274-7.